Your browser doesn't support javascript.
loading
Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study.
Stahl, Maximilian; Shallis, Rory M; Wei, Wei; Montesinos, Pau; Lengline, Etienne; Neukirchen, Judith; Bhatt, Vijaya R; Sekeres, Mikkael A; Fathi, Amir T; Konig, Heiko; Luger, Selina; Khan, Irum; Roboz, Gail J; Cluzeau, Thomas; Martínez-Cuadron, David; Raffoux, Emmanuel; Germing, Ulrich; Umakanthan, Jayadev Manikkam; Mukherjee, Sudipto; Brunner, Andrew M; Miller, Adam; McMahon, Christine M; Ritchie, Ellen K; Rodríguez-Veiga, Rebeca; Itzykson, Raphaël; Boluda, Blanca; Rabian, Florence; Tormo, Mar; Acuña-Cruz, Evelyn; Rabinovich, Emma; Yoo, Brendan; Cano, Isabel; Podoltsev, Nikolai A; Bewersdorf, Jan Philipp; Gore, Steven; Zeidan, Amer M.
Afiliación
  • Stahl M; Department of Internal Medicine Section of Hematology, Yale School of Medicine, New Haven, CT, USA.
  • Shallis RM; Department of Internal Medicine Section of Hematology, Yale School of Medicine, New Haven, CT, USA.
  • Wei W; Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
  • Montesinos P; Hospital Universitario y Politecnico La Fe, Valencia, Spain; & CIBERONC, Instituto Carlos III, University of Valencia, Madrid, Spain.
  • Lengline E; Hematology Department, Saint-Louis Hospital AP-HP, Paris, France.
  • Neukirchen J; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
  • Bhatt VR; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.
  • Sekeres MA; Leukemia Program, Cleveland Clinic, Cleveland, OH, USA.
  • Fathi AT; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Konig H; Indiana University Simon Cancer Center, Indianapolis, IN, USA.
  • Luger S; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Khan I; University of Illinois Cancer Center, Chicago, IL, USA.
  • Roboz GJ; Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY, USA.
  • Cluzeau T; CHU of Nice, Hematology Department, Cote d'Azur University, Nice, France.
  • Martínez-Cuadron D; Hospital Universitario y Politecnico La Fe, Valencia, Spain; & CIBERONC, Instituto Carlos III, University of Valencia, Madrid, Spain.
  • Raffoux E; Hematology Department, Saint-Louis Hospital AP-HP, Paris, France.
  • Germing U; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
  • Umakanthan JM; University of North Carolina Physician Network, Durham, NC, USA.
  • Mukherjee S; Leukemia Program, Cleveland Clinic, Cleveland, OH, USA.
  • Brunner AM; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Miller A; Indiana University Simon Cancer Center, Indianapolis, IN, USA.
  • McMahon CM; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Ritchie EK; University of Illinois Cancer Center, Chicago, IL, USA.
  • Rodríguez-Veiga R; Hospital Universitario y Politecnico La Fe, Valencia, Spain; & CIBERONC, Instituto Carlos III, University of Valencia, Madrid, Spain.
  • Itzykson R; Hematology Department, Saint-Louis Hospital AP-HP, Paris, France.
  • Boluda B; Hospital Universitario y Politecnico La Fe, Valencia, Spain; & CIBERONC, Instituto Carlos III, University of Valencia, Madrid, Spain.
  • Rabian F; Hospital Universitario y Politecnico La Fe, Valencia, Spain; & CIBERONC, Instituto Carlos III, University of Valencia, Madrid, Spain.
  • Tormo M; Hematology Department, Saint-Louis Hospital AP-HP, Paris, France.
  • Acuña-Cruz E; INCLIVA, University Clinical Hospital, Valencia, Spain.
  • Rabinovich E; Hospital Universitario y Politecnico La Fe, Valencia, Spain; & CIBERONC, Instituto Carlos III, University of Valencia, Madrid, Spain.
  • Yoo B; University of Illinois Cancer Center, Chicago, IL, USA.
  • Cano I; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Podoltsev NA; Hospital Universitario y Politecnico La Fe, Valencia, Spain; & CIBERONC, Instituto Carlos III, University of Valencia, Madrid, Spain.
  • Bewersdorf JP; Department of Internal Medicine Section of Hematology, Yale School of Medicine, New Haven, CT, USA.
  • Gore S; Department of Internal Medicine Section of Hematology, Yale School of Medicine, New Haven, CT, USA.
  • Zeidan AM; Department of Internal Medicine Section of Hematology, Yale School of Medicine, New Haven, CT, USA.
Leukemia ; 34(12): 3149-3160, 2020 12.
Article en En | MEDLINE | ID: mdl-32132655
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Leucocitosis Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Leucocitosis Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article